DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
Methylation of histone 3 at lysine 79 (H3K79) is one of the principal mechanisms involved in gene expression. The histone methyltransferase DOT1L, which mono-, di- and trimethylates H3K79 using S-adenosyl-L-methionine as a co-factor, is involved in cell development, cell cycle progression, and DNA d...
Main Authors: | Federica Sarno, Angela Nebbioso, Lucia Altucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-05-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2019.1699991 |
Similar Items
-
Genomic characterization of mixed lineage leukemias
by: S. Dogan
Published: (2020-03-01) -
Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia
by: Anne P. de Groot, et al.
Published: (2021-02-01) -
Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias
by: Sandra Cantilena, et al.
Published: (2022-06-01) -
Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
by: Anthony K. N. Chan, et al.
Published: (2019-05-01) -
DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation
by: Tanjing Song, et al.
Published: (2021-09-01)